Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03789110 |
|---|---|
| Brief Title: | NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer |
| First Submitted : | December 26, 2018 |
| First Submitted that Met QC Criteria : | December 26, 2018 |
| First Posted : | December 28, 2018 |
| Results First Submitted : | August 30, 2022 |
| Results First Submitted that Met QC Criteria : | August 30, 2022 |
| Results First Posted : | September 27, 2022 |
| Last Update Submitted that Met QC Criteria : | December 11, 2023 |
| Last Update Posted : | December 13, 2023 |